期刊中文名:心脏病学和治疗ISSN:2193-8261E-ISSN:2193-6544
该杂志国际简称:CARDIOL THER,是由出版商Adis, Springer Healthcare出版的一本致力于发布--研究新成果的的专业学术期刊。主要发表刊登有创见的学术论文文章、行业最新科研成果,扼要报道阶段性研究成果和重要研究工作的最新进展,选载对学科发展起指导作用的综述与专论,促进学术发展,为广大读者服务。该刊是一本国际优秀杂志,在国际上有很高的学术影响力。
《Cardiology And Therapy》是一本以English为主的开放获取国际优秀期刊,中文名称心脏病学和治疗,本刊主要出版、报道领域的研究动态以及在该领域取得的各方面的经验和科研成果,介绍该领域有关本专业的最新进展,探讨行业发展的思路和方法,以促进学术信息交流,提高行业发展。该刊已被国际权威数据库SCIE收录,为该领域相关学科的发展起到了良好的推动作用,也得到了本专业人员的广泛认可。该刊最新影响因子为3,最新CiteScore 指数为5.3。
本刊近期中国学者发表的论文主要有:
Author: Singh, Shashi Bhushan; Ng, Sze Jia; Lau, Hui Chong; Khanal, Kishor; Bhattarai, Sanket; Paudyal, Pranita; Shrestha, Bimash Babu; Naseer, Rizwan; Sandhu, Simran; Gokhale, Saket; Raynor, William Y. Y.
Author: Yu, Xuejing; Yang, Xianggui; Cao, Jinjin
Author: Patti, Giuseppe; Wang, Rosa; Marston, Xiaocong Li; Yeh, Yu-Chen; Zimmermann, Lisa; Ye, Xin; Gao, Xin; Brueggenjuergen, Bernd
Author: Tan, Hong; Li, Weimin; Huang, Zhouqing; Han, Yajun; Huang, Xuecheng; Li, Dongye; Xing, Xiaochun; Monsalvo, Maria Laura; Wu, You; Mao, Jackie; Xin, Lily; Chen, Jiyan
Cardiology And Therapy strives to be the leading publishing platform for innovative research results in the field of cardiovascular medicine. The goal of the journal is to facilitate the exchange of knowledge among medical professionals and researchers worldwide and to accelerate the development and application of cardiovascular therapies and interventions. The types of research the journal encourages range from initial basic science studies to late-stage clinical trials to long-term observational studies of patient outcomes.
Journals evaluate the safety and effectiveness of new drugs, devices or treatments at different stages. The risk factors and natural course of cardiovascular disease were explored through cohort studies and case-control studies. Use real-world data to evaluate the effectiveness of medical interventions in actual clinical practice. Focus on the patient's health status after treatment, including quality of life, functional status, and long-term prognosis. To analyze the cost-effectiveness of treatment methods for cardiovascular diseases, and to provide basis for rational allocation of medical resources.
按JIF指标学科分区 |
学科:CARDIAC & CARDIOVASCULAR SYSTEMS
收录子集:ESCI
分区:Q2
排名:72 / 220
百分位:
67.5% |
按JCI指标学科分区 |
学科:CARDIAC & CARDIOVASCULAR SYSTEMS
收录子集:ESCI
分区:Q2
排名:103 / 220
百分位:
53.41% |
JCR分区:JCR分区来自科睿唯安公司,JCR是一个独特的多学科期刊评价工具,为唯一提供基于引文数据的统计信息的期刊评价资源。每年发布的JCR分区,设置了254个具体学科。JCR分区根据每个学科分类按照期刊当年的影响因子高低将期刊平均分为4个区,分别为Q1、Q2、Q3和Q4,各占25%。JCR分区中期刊的数量是均匀分为四个部分的。
学科类别 | 分区 | 排名 | 百分位 |
大类:Medicine 小类:Cardiology and Cardiovascular Medicine | Q2 | 107 / 387 |
72% |
该杂志是一本国际优秀杂志,在国际上有较高的学术影响力,行业关注度很高,已被国际权威数据库SCIE收录,该杂志在综合专业领域专业度认可很高,对稿件内容的创新性和学术性要求很高,作为一本国际优秀杂志,一般投稿过审时间都较长,投稿过审时间平均 6 Weeks ,如果想投稿该刊要做好时间安排。版面费不祥。该杂志近两年未被列入预警名单,建议您投稿。如您想了解更多投稿政策及投稿方案,请咨询客服。
若用户需要出版服务,请联系出版商。